Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioventus (BVS) Shares Outstanding (Weighted Average) (2021 - 2026)

Bioventus filings provide 5 years of Shares Outstanding (Weighted Average) readings, the most recent being $66.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 3.21% to $66.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $66.6 million, a 3.21% increase, with the full-year FY2025 number at $66.6 million, up 3.21% from a year prior.
  • Shares Outstanding (Weighted Average) hit $66.6 million in Q4 2025 for Bioventus, roughly flat from $66.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $66.9 million in Q3 2025 to a low of $41.8 million in Q2 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $62.4 million (2023), compared with a mean of $59.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 47.05% in 2022 and later grew 1.4% in 2023.
  • Bioventus' Shares Outstanding (Weighted Average) stood at $45.5 million in 2021, then surged by 35.0% to $61.4 million in 2022, then increased by 2.05% to $62.6 million in 2023, then increased by 3.03% to $64.5 million in 2024, then rose by 3.21% to $66.6 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $66.6 million (Q4 2025), $66.9 million (Q3 2025), and $66.3 million (Q2 2025) per Business Quant data.